EMV emvision medical devices ltd

EMvision Research Notes, page-2486

  1. 77 Posts.
    lightbulb Created with Sketch. 49
    I was disappointed in the Stage 2 insights announced on 27th March. We did get reassuring words like "strong AI performance" and results "align with expectations" but we did not get any details. For example, with the 18 bleeds I would have liked the number of high confidence bleeds, low confidence bleeds and if any false results. To me it is clear the AI algorithms need more fine tuning and that is the task in the Stage 3 trial.

    Because of this lack of detail, it is clear some investors are assuming the worse and selling their shares. I remain confident our novel microwave technology works and in due course we will have 2 successful commercial products. I am delighted to have the opportunity to be buying more shares around $2.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.80
Change
0.000(0.00%)
Mkt cap ! $153.5M
Open High Low Value Volume
$1.80 $1.81 $1.77 $88.77K 49.72K

Buyers (Bids)

No. Vol. Price($)
1 876 $1.78
 

Sellers (Offers)

Price($) Vol. No.
$1.80 3875 1
View Market Depth
Last trade - 14.41pm 27/06/2025 (20 minute delay) ?
EMV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.